BMV:XBI Holdings Information

BMV:XBI is an equity ETF with a total of 156 individual holdings. The top holdings are Apellis Pharmaceuticals stock at 1.82%, Madrigal Pharmaceuticals at 1.43%, Alkermes at 1.41%, TG Therapeutics at 1.35%, and Insmed at 1.31%.

Total Holdings

156

Top 10 Percentage

13.58%

Asset Class

Equity

ETF Category

Health Care

Assets

133.80B

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	APLS	Apellis Pharmaceuticals, Inc.	1.82%	3,835,144
2	MDGL	Madrigal Pharmaceuticals, Inc.	1.43%	222,028
3	ALKS	Alkermes plc	1.41%	3,450,990
4	TGTX	TG Therapeutics, Inc.	1.35%	3,416,496
5	INSM	Insmed Incorporated	1.31%	687,450
6	SRRK	Scholar Rock Holding Corporation	1.31%	2,219,385
7	APGE	Apogee Therapeutics, Inc.	1.27%	1,283,234
8	SMMT	Summit Therapeutics Inc.	1.26%	5,504,813
9	PTGX	Protagonist Therapeutics, Inc.	1.21%	993,361
10	TWST	Twist Bioscience Corporation	1.21%	2,045,326
11	NTRA	Natera, Inc.	1.19%	487,358
12	NUVL	Nuvalent, Inc.	1.19%	957,788
13	EXEL	Exelixis, Inc.	1.19%	2,295,480
14	ARWR	Arrowhead Pharmaceuticals, Inc.	1.18%	1,649,442
15	CYTK	Cytokinetics, Incorporated	1.18%	1,506,218
16	KYMR	Kymera Therapeutics, Inc.	1.18%	1,175,615
17	PRAX	Praxis Precision Medicines, Inc.	1.18%	322,767
18	UTHR	United Therapeutics Corporation	1.17%	175,965
19	PTCT	PTC Therapeutics, Inc.	1.16%	1,459,346
20	TVTX	Travere Therapeutics, Inc.	1.16%	3,238,755
21	MIRM	Mirum Pharmaceuticals, Inc.	1.16%	1,044,558
22	BBIO	BridgeBio Pharma, Inc.	1.16%	1,342,366
23	KRYS	Krystal Biotech, Inc.	1.15%	375,892
24	CGON	CG Oncology, Inc.	1.15%	1,444,365
25	NBIX	Neurocrine Biosciences, Inc.	1.15%	739,749

Showing 25 of 156 holdings

Subscribe to see the full list

Activate Now

As of Apr 2, 2026